| Sources | Names Used |
|---|---|
| CTRPv2 | Compound 23 citrate |
| PharmacoGx | Compound 23 citrate |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAF5L | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | ZNF473 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | PKDREJ | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | POLD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | NABP1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | PFKFB4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GDE1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |
| mRNA | DAB1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | SGCB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | C19orf81 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
